XL Lin
Seminars
Wednesday 24th September 2025
Cell Line to Phase 1 Clinical Trial Material: Engineering a HLA-G Cancer targeting Exosome Platform
3:45 pm
- Cell line creation and single clone for HEK293T HLA-G and scaling up using Tide Motion
- In vitro, in vivo data and CMC
- cGMP engineering run and aseptic process simulation leading to clinical manufacturing
